MVision AI is delighted to announce that we have received our 2nd order for the Republic of Ireland from St. Luke’s Radiation Oncology Network (SLRON)

Finland, Helsinki, February 19, 2024

The contract for installing Contour+ Guideline Based AI Segmentation tool has been won through the public tender process and implies a three-year agreement for 5,000 scans per year. This order comes in quick succession following MVision AI’s successful award of the tender from the Republic of Ireland’s Health Service Executive (HSE) for the installation of our Contour+ auto contouring solution at Cork University Hospital [1].

At MVision AI, we are delighted to partner with the St. Luke Radiation Oncology Network, supporting them in fulfilling their mission of striving for excellence in cancer treatment, patient care, research, and education. We eagerly anticipate witnessing the impact that the implementation of Contour+ will have on the network and the efficiency of day-to-day operations. Furthermore, we are pleased to collaborate with SLORN on the implementation of Guide & Verify, our newly released solutions designed to enhance your staff’s expertise and facilitate volumetric comparisons of contours in the Auto-segmentation space“, says Sara La Sivita, EMEA Sales Director of MVision AI.

SLRON provides the largest radiation oncology service in Ireland across three centers in St. Luke’s Hospital, Rathgar and on the campuses of St. James’s Hospital and Beaumont Hospital. SLRON is dedicated to excellence in patient care, research and education with patients and committed to providing the most modern radiation oncology service possible.

Phil Neale, Xiel Key Account Consultant added: “This partnership with the HSE follows a strong tradition of adoption of new technologies that benefit patients, and we are delighted to be part of that. It is a pleasure seeing that the MVision AI GBS™ solution installed at St Luke’s Radiation Oncology Network is already relieving effing pressures , and we expect the benefits on treatment waiting times to be borne out in the coming months. We thank the team at St Luke’s for their work in getting this technology installed, and are looking forward to a continued partnership that benefits patients for years to come”.

About MVision AI
MVision AI is an innovative software service provider for radiotherapy treatment planning. Our AI-powered automatic segmentation tool, Contour+, helps to standardize contouring and automate segmentation to streamline the radiotherapy treatment planning workflow.
MVision.ai
MVision AI Linkedin page
MVision AI Facebook page
MVision AI Twitter page

About Xiel.
Xiel is a specialist distributor of medical technologies in the UK and Ireland. We work with global leading solution providers; therefore, continuously improving efficiency and quality for our customers. Our partners research and develop highly specific products for what is often a small world market. The expertise of Xiel lies in our deep understanding of the structure and organization of radiotherapy departments in the UK and Ireland, for us to advise on the best solutions possible. Xiel. Exceptional Products. Extraordinary Service. Everyday.
Xiel.co.uk
Xiel Linkedin page

About St Luke’s Radiation Oncology Network
Since it opened in May 1954, St Luke’s Hospital in Rathgar, Dublin, has been caring for cancer patients from all over Ireland. The St. Luke’s Radiation Oncology Network is dedicated to being a world class leader in cancer treatment, patient care, research and education. In striving for this excellence, the holistic needs of patients and their families are SLRON’s greatest concern.
Stlukesnetwork.ie

[1] MVision.ai – Press Release: MVision AI is selected to provide its Contour+ solution by the Republic of Ireland’s Health Service Executive (HSE) for its first installation in the country.

Our Newsletter

Subscribe to get information, latest news and other interesting offers about MVision AI

Related Posts

13.12.2024

Saad Ullah Akram Appointed as CEO of MVision AI

Helsinki, Finland – MVision AI, a leading provider of AI-powered solutions for radiation therapy treatment planning, announces the appointment of Saad Ullah Akram as its new Chief Executive Officer. Known for its commitment to streamlining workflows and enhancing treatment quality in cancer care, MVision AI is embarking on an exciting…

Press Releases

20.11.2024

MVision AI Ranked Among the Top 10 in Deloitte Technology Fast 50 Finland for 2024

Helsinki, Finland, 20 November 2024 – MVision AI, a leading innovator in AI-driven solutions for oncology, is proud to announce its recognition among the top ten companies in the Deloitte Technology Fast 50 Finland 2024 ranking. This prestigious award acknowledges MVision AI's rapid growth and its mission-driven advancements in making…

Press Releases

7.11.2024

Safe and Ethical AI in Radiation Oncology: Regulations and MVision’s Compliance

Technology is evolving, and the same applies to Radiation Oncology. New ways and new tools require new rules. Artificial intelligence (AI)  brings tremendous potential, so the world has to learn how to get the best of it, safely.  Al systems identified as high-risk have to comply with strict requirements, including…

Articles